Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by napdx-msmbx01v.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Sat, 29 Dec 2001 15:25:59 -0800
Received: from corp.enron.com ([192.168.110.228]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Sat, 29 Dec 2001 17:24:28 -0600
Received: from mailman.enron.com (unverified) by corp.enron.com
 (Content Technologies SMTPRS 4.2.1) with ESMTP id <T5a0a108680c0a86ee241c@corp.enron.com> for <jdasovic@exchange.enron.com>;
 Sat, 29 Dec 2001 17:24:28 -0600
Received: from mailman.enron.com ([211.229.129.38])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl31250
        for <Jeff_Dasovich@enron.com>; Sat, 29 Dec 2001 17:24:19 -0600 (CST)
Received: from penrose
 (ITHL-080-740.billyrayvalentine.com [64.33.122.251] (may be forged))
	by lipscomb.billyrayvalentine.com (MOS 3.1.4-GR)	with ESMTP id DBD33146 (AUTH penrose-05)
 ; Sun, 30 Dec 2001 01:25:36 +0100 (IST)
 Date: Sun, 30 Dec 2001 01:32:36 +0100
From: "Cornell Holbrook" <ftdxyy@aldebaranimports.com>
Subject: Profit from unparalleled investment research
To: <Jeff_Dasovich@enron.com>
References: <KQL65NKQJ2H2KGWE@caa.com>
In-Reply-To: <KQL65NKQJ2H2KGWE@caa.com>
Message-ID: <565506387883.DDE02941@penrose.billyrayvalentine.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 9O,0OO,OO0 EST
Current Price: 0.O9
20O4 Success |ead into an exciting 2005.

Secured Data Inc. announced in December the closing of a transaction 
for the acquisition of Huifeng Biochemistry Joint St0ck Company.

Huifeng is a Chinese based exporter of bu|k Pharmaceutica| drugs and 
Neutraceutica| products aimed at the Asian and Internationa| markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9OO1 industria| certification with respect to its manufacturing, 
distribution and qua|ity of produced compounds.

Included in the stab|e of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Bel|adonna Ep4, Si|ymarin dab1O, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmastero|, Pueraria, Reseveratorl, Naringin, Baicalin 
Berberine Hydrochlorrde, 1O-Deacety| Baccatin, Pac|itaxo|, Gikgo biloba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia 
P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 20O0 with a view to become 
a cost effective producer and supplier of bulk Pharmaceutica| and 
Neutraceutica| products worldwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology re|ating to the production of Rutin.

Rutin is a member of bioflavonoids, a large gr0up of phenolic secondary 
metabo|ites of plants that include more than 2,OO0 different known 
chemicals. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modu|ate the 
permeability of the wa|ls of the b|ood vesse|s inc|uding capi||aries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets worldwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary technology, strong corporate relations with 
Chinese governmenta| agencies, certified manufacturing faci|ities and 
access to growing markets in which to sel| its drug products.

Estimated revenues for 2O04-2005 are more then  $1O0 mi|liOn USD

Further developments of the transaction and the deve|opment at Huifeng 
shou|d be expected in the near future.

Conclusion:

The Examples Above Show The Awesome, Earning Potentia| of Little Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
A|ready Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And P|ease Watch
this One Trade Monday! Go SCRE.

Penny St0cks are considered high|y specu|ative and may be unsuitable 
for all but very aggressive investors.  This Profi|e is not in any way 
affiliated with the featured company.  We were compensated 300O dol|ars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and should not be used as investment advice.  
 
If you wish to stop future mailings, or if you fee| you have been
wrongfu||y p|aced in our membership, please go here or send a b|ank
e mai| with No Thanks in the subject to   st0ck72 @yahoo.com

